The Patent Finder
US

FUSION PROTEIN CONSTRUCTS COMPRISING ANTI-C3d ANTIBODY AND CR1 POLYPEPTIDE

US 11,053,305 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Q32 Bio Inc., an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Dec 11, 2039 · Medium confidence

Why Medium: A parent in the chain could not be resolved.

Filed Jan 24, 2020 as application 16/752,074 · Granted Jul 6, 2021
Base term, 20 years from filing
Today
20 years from filing
2019 2039
Clock starts
Dec 11, 2019
Term ends
Dec 11, 2039
Granted
Jul 6, 2021
base term fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Dec 11, 2019, when application PCT/US2019/065741, the earliest non-provisional in its chain, was filed (this one was filed Jan 24, 2020); a parent in its chain could not be resolved (the next row)Dec 11, 2039High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderDec 11, 2039Medium confidence

This family

Application PCT/US2019/065741PCT application
no patent term
no patent term
US 11,053,305this patent
Dec 2039
Dec 2039
US 11,053,306In force
Dec 2039
Dec 2039
US 11,879,008In force
Dec 2039
Dec 2039
Application 18/542,100Pending
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
May 4, 2020
Reel 52563, frame 943
Curtis, Michael Steven; Storek, Michael; Violette, Shelia Marie; Kalled, Susan L.; Fahnoe, Kelly C.; Huang, Cheng Ran; Stark, Ellen Garber; Taylor, Frederick Robbins; Caravella, Justin Andrew; Holers, Vernon MichaelQ32 Bio Inc.Assignment of Assignor's Interest
May 8, 2020
Reel 52618, frame 92
Admirx Inc.Q32 Bio Inc.Change of Name
Jan 7, 2026
Reel 73393, frame 809
Q32 Bio Inc.; Q32 Bio Operations Inc.Akebia Therapeutics, Inc.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited